Eczema Trial, Recruiting (NCT06815380)

Eczema Trial, Recruiting NCT06815380 Sponsor: Almirall, S.A. Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT06815380 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older and have been diagnosed with moderate-to-severe atopic dermatitis (a serious form of eczema)
Your doctor has already prescribed you lebrikizumab as part of your normal treatment for your atopic dermatitis
You are willing and able to take part in the study and are prepared to sign a written consent form

Who may not be able to join:

You have had an allergic reaction to lebrikizumab (Ebglyss®) or any of its ingredients
You currently have a parasitic worm infection (such as hookworm or tapeworm) — though you may still be eligible after the infection has been treated
You are currently receiving certain types of live vaccines at the same time
You are pregnant, unless your doctor decides the potential benefit outweighs any potential risk
You are already taking part in another clinical trial, or plan to do so during this study
Your doctor feels you are unable to follow the study requirements, or that participation would not be appropriate for you
Your medical records are not accessible to the doctors who need to collect your background health information

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0034 932 913 986

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06815380

Sponsor: Almirall, S.A.

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

Trial contact: 0034 932 913 986

More information: https://clinicaltrials.gov/study/NCT06815380

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older and have been diagnosed with moderate-to-severe atopic dermatitis (a serious form of eczema)
Your doctor has already prescribed you lebrikizumab as part of your normal treatment for your atopic dermatitis
You are willing and able to take part in the study and are prepared to sign a written consent form

Who may not be able to join:

You have had an allergic reaction to lebrikizumab (Ebglyss®) or any of its ingredients
You currently have a parasitic worm infection (such as hookworm or tapeworm) — though you may still be eligible after the infection has been treated
You are currently receiving certain types of live vaccines at the same time
You are pregnant, unless your doctor decides the potential benefit outweighs any potential risk
You are already taking part in another clinical trial, or plan to do so during this study
Your doctor feels you are unable to follow the study requirements, or that participation would not be appropriate for you
Your medical records are not accessible to the doctors who need to collect your background health information

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Almirall, S.A.

Registry

ClinicalTrials.gov

Start date

23 January 2025

Est. completion

1 March 2029

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Absolute Measures in the Overall Health-related Well-being Index Evaluated Through World Health Organization (WHO-5) Score Throughout the Study Observation Period; Change From Baseline in the Overall Health-related Well-being Index Evaluated Through WHO-5 Score Throughout the Study Observation Period

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov